Anti-osteoporotic constituents from Indian medicinal plants

Phytomedicine

Volumn 17, Issue 13, 2010, Pages 993-999

  Kumar, Manmeet ^a   Rawat, Preeti ^a   Dixit, Preeti ^a   Mishra, Devendra ^a   Gautam, Abnish K ^a   Pandey, Rashmi ^a   Singh, Divya ^a   Chattopadhyay, Naibedya ^a   Maurya, Rakesh ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Allophylus serratus; Cissus quadrangularis; Differentiation; Osteoblast; Osteogenic; Vitex negundo

Indexed keywords

ALLOPHYLUS SERRATUS EXTRACT; CISSUS QUADRANGULARIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; VITEX NEGUNDO EXTRACT;

ALLOPHYLUS SERRATUS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CISSUS QUADRANGULARIS; DRUG EFFECT; IN VITRO STUDY; INDIAN; ISOLATION PROCEDURE; MEDICINAL PLANT; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PLANT LEAF; PLANT STEM; PRIORITY JOURNAL; RAT; VITEX; VITEX NEGUNDO;

ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; CISSUS; INDIA; OSTEOBLASTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; SAPINDACEAE; VITEX;

ALLOPHYLUS SERRATUS; CISSUS QUADRANGULARIS; VITEX NEGUNDO;

EID: 77957792277     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.03.014     Document Type: Article

References (37)

1. Anderson J.J., Garner S.C. Phytoestrogens and bone. Bailieres. Clin. Endocrinol. Metab. 1998, 12:543-557.
2. Baumann B.D., Wronski T.J. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 1995, 16:247-253.
3. Boligon A.A., Feltrin A.C., Machado M.M., Janovik V., Athayde M.L. HPLC analysis and phytoconstituents isolated from ethyl acetate fraction of Scutia buxifolia Reiss. leaves. Lat. Am. J. Pharm. 2009, 28:121-124.
4. Brown E.M. Is the calcium receptor a molecular target for the actions of strontium on bone?. Osteoporos. Int. 2003, 14:S25-S34.
5. Brzezinski A., Debi A. Phytoestrogens: the " natural" selective estrogen receptor modulators. Eu. J. Obstet. Gynecol. Rep. Biol. 1999, 85:47-51.
6. Cappuzzo K., Delafuente J. Teriparatide for severe osteoporosis. Ann. Pharmacother. 2004, 38:294-302.
7. Chang J.H., Gill S., Settleman J., Parsons S.J. c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J. Cell Biol. 1995, 130:355-368.
8. Chiechi L.M., Lobascio A., Grillo A., Valerio T. Phytoestrogen-containing food and prevention of postmenopausal osteoporosis and cardiovascular diseases. Minerva Ginecol. 1999, 5:343-348.
9. Dempster D.W., Lindsay R. Pathogenesis of osteoporosis. Lancet 1993, 341:797-801.
10. Dharmani P., Mishra P.K., Maurya R., Chauhan V.S., Palit G. Allophylus serratus: a plant with potential anti-ulcerogenic activity. J. Ethnopharmacol. 2005, 99:361-366.
11. Dijke P. Curr. Med. Res. Opin. 2006, 22:S7.
12. Domínguez X.A., Marroquin J., Gutierrez M.M. Triterpene acetates and d-(+)-pinitol from Dryanaria drummondii. Phytochemistry 1975, 14:815-816.
13. Farnsworth N.R., Akerele O., Bingel A.S., Soejarto D.D., Guo Z. Medicinal plants in therapy. Bull. World Health Org. 1985, 63:965-981.
14. Fitzpatrick L. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clin. Proc. 1999, 74:601-607.
15. Ghanta S., Banerjee A., Poddar A., Chattopadhyay S. Oxidative DNA damage preventive activity and antioxidant potential of Stevia rebaudiana (Bertoni), a natural sweetener. J. Agric. Food Chem. 2007, 55:10962-10967.
16. Hodsman A.B., Watson P.H., Drost D., Holdsworth D., Thronton M., Hock J., Bryant H., Fraher L.J. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat. Bone 1999, 24:451-455.
17. Ishizuya T., Yokose S., Hori M., Noda T., Suda T., Yoshiki S. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J. Clin. Invest. 1997, 99:2961-2970.
18. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 1999, 104:439-446.
19. Johannes C.B., Crawford S.L., Posner J.G., McKinlay S.M. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am. J. Epidemiol. 1994, 140:439-452.
20. Kung A. Management of osteoporosis in Hong Kong. Clin. Calcium 2004, 14:108-111.
21. Lai B.M.H., Cheung C.L., Luk K.D.K., Kung A.W.C. Estrogen receptor alpha CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women. Osteoporos. Int. 2007, 19:571-579.
22. Linkhart T.A., Mohan S. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-I1 from neonatal mouse calvaria in organ culture. Endocrinology 1989, 125:1484-1491.
23. Maurya R., Yadav D.K., Singh G., Bhargavan B., Narayana M.P.S., Sahai M., Singh M.M. Osteogenic activity of constituents from Butea monosperma. Bioorg. Med. Chem. Lett. 2009, 19:610-613.
24. Mundy G.R. Visions for the future in osteoporosis research. Osteoporos. Int. 1993, 2(Suppl.):29S-34S.
25. Phillipson J.D., Anderson L.A. Ethnopharmacology and western medicine. J. Ethnopharmacol. 1989, 25:61-72.
26. Prasad G.C., Udupa K.N. Effect of Cissus quadrangularis in accelerating healing process of experimentally fractured radius-ulna of dog: a preliminary study. Indian J. Med. Res. 1964, 52:480.
27. Rosen C.J., Donahue L.R. Insulin-like growth factors and bone: the osteoporosis connection revisited. Proceedings of the Society for Experimental Biology and Medicine, vol. 219 1998, 1-7.
28. Rosen C.J., Bilezikian J.P. Anabolic therapy for osteoporosis. J. Clin. Endocrinol. Metab. 2001, 86:957-964.
29. Sathiamoorthy B., Gupta P., Kumar M., Chaturvedi A.K., Shukla P.K., Mauryaa R. New antifungal flavonoid glycoside from Vitex negundo. Bioorg. Med. Chem. Let. 2007, 17:239-242.
30. Sharan K., Siddiqui J.A., Sawarnkar G., Maurya R., Chattopadhyay N. Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies. Curr. Med. Chem. 2009, 16:1138-1157.
31. Singh G., Rawat P., Maurya R. Constituents of Cissus quadrangularis. Nat. Prod. Res. 2007, 21:522-528.
32. Trivedi R., Kumar S., Kumar A., Siddiqui J.A., Swarnkar G., Gupta V., Kendurker A., Dwivedi A.K., Romero J.R., Chattopadhyay N. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol. Cell Endocrinol. 2008, 289:85-93.
33. Tolstoi L.G., Levin R.M. Osteoporosis-the treatment controversy. Nutr. Today 1992, 27:1-6.
34. Ulubelen A., Cetin E.T., Guran A., Iyenger M.A. Flavonoid compounds of Genista tinctoria. Lloydia 1971, 34:258-259.
35. Watson P., Lazowski D., Han V., Fraher L., Steer B., Hodsman A. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 1995, 16:365-375.
36. Yamaguchi M., Sugimoto E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase. Mol. Cell Biochem. 2000, 214:97-102.
37. Yusuf S., Anand S.S. Oral anticoagulants in patients with coronary artery disease. J. Am. Coll. Cardiol. 2003, 41:62-69.